KIN-102

N/A

Report date: 2025/01/26 18:31:34

Base Information

Drug NameKIN-102
Drug Alias NameTLR9 agonist (Kinimmune Inc)glatiramer acetate + CpG (Kinimmune)KIN-102
ClassificationBiologics
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesKinimmune Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A